Sara Margret Daðadóttir, Arnar Bragi Ingason, Johann Pall Hreinsson, Einar Stefan Björnsson
{"title":"肝硬化和非肝硬化患者消化道出血的比较。","authors":"Sara Margret Daðadóttir, Arnar Bragi Ingason, Johann Pall Hreinsson, Einar Stefan Björnsson","doi":"10.1080/00365521.2024.2386451","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Upper gastrointestinal bleeding (GIB) in patients has been well-characterized in liver cirrhosis but studies on lower GIB are limited. The clinical characteristics, management and outcomes in patients with and without liver cirrhosis was compared to determine the overall features of GIB in patients with liver cirrhosis compared with non-cirrhotics.</p><p><strong>Methods: </strong>A retrospective study on cirrhotics hospitalized for GIB 2010-2021, matched with control group of non-cirrhotics (1:4) for upper vs. lower GIB. Patients with overt bleeding leading to hospitalization were included.</p><p><strong>Results: </strong>Overall, 396 patients had cirrhosis, 267 (67%) men, median age 62, alcoholic etiology 177/396 (45%), median MELD 12 (range 6-32). Overall 102 cirrhotics had GIB, matched with 391 non-cirrhotics. Overall 87 (85%) cirrhotic patients had upper and 15% lower GIB. Compared to non-cirrhotics, the cause of GIB was more commonly acute variceal bleeding (AVB) (42% vs. 1%), hemorrhoids 40% vs. 6% (<i>p</i> = 0.002), less commonly gastric ulcer 13% vs. 31% (<i>p</i> < 0.001), duodenal ulcer 9% vs. 29% (<i>p</i> < 0.001), 5% of cirrhotics used NSAIDs vs. 26% of controls (<i>p</i> < 0.001). Rebleeding occurred in 14% of cirrhotics vs. 3% in controls (<i>p</i> < 0.001). Only one cirrhotic patient (1%) died from GIB vs. 0.8% of controls within 45 days. Overall mortality 45 days after hospitalization was 10% in cirrhotics vs. 5% in controls (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Bleeding from gastric and duodenal ulcers were less common in cirrhotics than in controls. Bleeding from hemorrhoids was more common in cirrhotics. Mortality due to GIB was low in both groups but overall mortality was significantly higher in cirrhotics.</p>","PeriodicalId":21461,"journal":{"name":"Scandinavian Journal of Gastroenterology","volume":" ","pages":"1081-1086"},"PeriodicalIF":1.6000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of gastrointestinal bleeding in patients with and without liver cirrhosis.\",\"authors\":\"Sara Margret Daðadóttir, Arnar Bragi Ingason, Johann Pall Hreinsson, Einar Stefan Björnsson\",\"doi\":\"10.1080/00365521.2024.2386451\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Upper gastrointestinal bleeding (GIB) in patients has been well-characterized in liver cirrhosis but studies on lower GIB are limited. The clinical characteristics, management and outcomes in patients with and without liver cirrhosis was compared to determine the overall features of GIB in patients with liver cirrhosis compared with non-cirrhotics.</p><p><strong>Methods: </strong>A retrospective study on cirrhotics hospitalized for GIB 2010-2021, matched with control group of non-cirrhotics (1:4) for upper vs. lower GIB. Patients with overt bleeding leading to hospitalization were included.</p><p><strong>Results: </strong>Overall, 396 patients had cirrhosis, 267 (67%) men, median age 62, alcoholic etiology 177/396 (45%), median MELD 12 (range 6-32). Overall 102 cirrhotics had GIB, matched with 391 non-cirrhotics. Overall 87 (85%) cirrhotic patients had upper and 15% lower GIB. Compared to non-cirrhotics, the cause of GIB was more commonly acute variceal bleeding (AVB) (42% vs. 1%), hemorrhoids 40% vs. 6% (<i>p</i> = 0.002), less commonly gastric ulcer 13% vs. 31% (<i>p</i> < 0.001), duodenal ulcer 9% vs. 29% (<i>p</i> < 0.001), 5% of cirrhotics used NSAIDs vs. 26% of controls (<i>p</i> < 0.001). Rebleeding occurred in 14% of cirrhotics vs. 3% in controls (<i>p</i> < 0.001). Only one cirrhotic patient (1%) died from GIB vs. 0.8% of controls within 45 days. Overall mortality 45 days after hospitalization was 10% in cirrhotics vs. 5% in controls (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Bleeding from gastric and duodenal ulcers were less common in cirrhotics than in controls. Bleeding from hemorrhoids was more common in cirrhotics. Mortality due to GIB was low in both groups but overall mortality was significantly higher in cirrhotics.</p>\",\"PeriodicalId\":21461,\"journal\":{\"name\":\"Scandinavian Journal of Gastroenterology\",\"volume\":\" \",\"pages\":\"1081-1086\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00365521.2024.2386451\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00365521.2024.2386451","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:肝硬化患者上消化道出血(GIB)的特征已被充分描述,但有关下消化道出血的研究却很有限。为了确定与非肝硬化患者相比,肝硬化患者 GIB 的总体特征,我们对有肝硬化和无肝硬化患者的临床特征、管理和预后进行了比较:方法:对 2010-2021 年因 GIB 住院的肝硬化患者进行回顾性研究,并与非肝硬化患者对照组(1:4)就上部与下部 GIB 进行配对。研究对象包括因明显出血而住院的患者:共有 396 例肝硬化患者,其中男性 267 例(67%),中位年龄 62 岁,酒精性病因 177/396 例(45%),中位 MELD 12 例(6-32)。102名肝硬化患者患有GIB,391名非肝硬化患者患有GIB。87名(85%)肝硬化患者患有上部GIB,15%患有下部GIB。与非肝硬化患者相比,GIB 的病因更常见的是急性静脉曲张出血(AVB)(42% 对 1%)、痔疮(40% 对 6%)(P = 0.002),较少见的是胃溃疡(13% 对 31%)(P P P P P 结论:肝硬化患者的胃溃疡和十二指肠溃疡出血少于对照组。痔疮出血在肝硬化患者中更为常见。两组患者因 GIB 导致的死亡率均较低,但肝硬化患者的总死亡率明显较高。
Comparison of gastrointestinal bleeding in patients with and without liver cirrhosis.
Objectives: Upper gastrointestinal bleeding (GIB) in patients has been well-characterized in liver cirrhosis but studies on lower GIB are limited. The clinical characteristics, management and outcomes in patients with and without liver cirrhosis was compared to determine the overall features of GIB in patients with liver cirrhosis compared with non-cirrhotics.
Methods: A retrospective study on cirrhotics hospitalized for GIB 2010-2021, matched with control group of non-cirrhotics (1:4) for upper vs. lower GIB. Patients with overt bleeding leading to hospitalization were included.
Results: Overall, 396 patients had cirrhosis, 267 (67%) men, median age 62, alcoholic etiology 177/396 (45%), median MELD 12 (range 6-32). Overall 102 cirrhotics had GIB, matched with 391 non-cirrhotics. Overall 87 (85%) cirrhotic patients had upper and 15% lower GIB. Compared to non-cirrhotics, the cause of GIB was more commonly acute variceal bleeding (AVB) (42% vs. 1%), hemorrhoids 40% vs. 6% (p = 0.002), less commonly gastric ulcer 13% vs. 31% (p < 0.001), duodenal ulcer 9% vs. 29% (p < 0.001), 5% of cirrhotics used NSAIDs vs. 26% of controls (p < 0.001). Rebleeding occurred in 14% of cirrhotics vs. 3% in controls (p < 0.001). Only one cirrhotic patient (1%) died from GIB vs. 0.8% of controls within 45 days. Overall mortality 45 days after hospitalization was 10% in cirrhotics vs. 5% in controls (p < 0.001).
Conclusions: Bleeding from gastric and duodenal ulcers were less common in cirrhotics than in controls. Bleeding from hemorrhoids was more common in cirrhotics. Mortality due to GIB was low in both groups but overall mortality was significantly higher in cirrhotics.
期刊介绍:
The Scandinavian Journal of Gastroenterology is one of the most important journals for international medical research in gastroenterology and hepatology with international contributors, Editorial Board, and distribution